Why Abzena?
Our focused approach.
Accelerate your path to market with our range of advanced biologic services & technologies that help move your drug candidate forward.
Drug candidates in the biologics development pipeline are increasingly innovative. They are also more complex. As a highly specialized, leading complex biologics CDMO, Abzena have the experience to accelerate your path to the clinic or commercialization for mammalian, microbial, and bioconjugate modalities.
Through our complex chemistry expertise and seamless technology solutions, we provide comprehensive support from antibody discovery and developability, lead selection and optimization, through to commercial manufacturing for biologic drug candidates.
We deliver end-to-end solutions for:
Abzena’s genuine scientific and technical experts focus and collaborate with you on streamlining biologics development and manufacturing programs proactively. We de-risk and challenge outdated assumptions. Our end-to-end support means we can do what is best for your biologics program to move forwards.
The asset you’re developing right now can make a real difference for human health. Let us use our wealth of experience to deploy the best technologies, shorten lead times and implement effective risk mitigation strategies.